Global Pharmaceuticals & Biotech Leverage Leaders

Kalbe Farma

Market Cap: Rp44.6t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Financière de Tubize

Market Cap: €9.7b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Vaxcyte

Market Cap: US$8.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Dianthus Therapeutics

Market Cap: US$4.1b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Stevanato Group

Market Cap: US$4.2b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Biogen

Market Cap: US$26.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

ADMA Biologics

Market Cap: US$3.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Corcept Therapeutics

Market Cap: US$3.4b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Exelixis

Market Cap: US$10.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Tasly Pharmaceutical Group

Market Cap: CN¥21.3b

Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.

Aurobindo Pharma

Market Cap: ₹737.0b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥41.2b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Sun Pharmaceutical Industries

Market Cap: ₹4.3t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Alkem Laboratories

Market Cap: ₹639.9b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

D&D Pharmatech

Market Cap: ₩3.6t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Imeik Technology DevelopmentLtd

Market Cap: CN¥42.3b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥376.8b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Otsuka Holdings

Market Cap: JP¥5.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Zhejiang Medicine

Market Cap: CN¥15.4b

Manufactures and sells life nutrition and medical products in China and internationally.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥35.0b

Asymchem Laboratories (Tianjin) Co., Ltd.

Beam Therapeutics

Market Cap: US$2.5b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

IDEAYA Biosciences

Market Cap: US$3.1b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Wave Life Sciences

Market Cap: US$2.3b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Bachem Holding

Market Cap: CHF 4.6b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Camurus

Market Cap: SEK 28.1b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Sanofi

Market Cap: €92.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Catalyst Pharmaceuticals

Market Cap: US$2.8b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Regeneron Pharmaceuticals

Market Cap: US$77.7b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$3.6b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Structure Therapeutics

Market Cap: US$4.0b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

United Therapeutics

Market Cap: US$23.4b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥14.8b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Abbott India

Market Cap: ₹558.8b

Operates as a pharmaceutical company in India.

Cipla

Market Cap: ₹1.0t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥14.8t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.